Alectinib in Crizotinib-Refractory ALK-Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Study

Overview of attention for article published in Journal of Clinical Oncology, November 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news: 2 news outlets
policy: 2 policy sources
twitter: 21 X users

patent: 1 patent
facebook: 1 Facebook page
reddit: 1 Redditor

Citations

dimensions_citation: 537 Dimensions

Readers on

mendeley: 260 Mendeley

Summary News Policy documents X Patents Facebook Reddit Dimensions citations

So far, Altmetric has seen 1 Reddit thread.

Alectinib in Crizotinib-Refractory ALK-Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Study

User montaukwhaler, in the non small cell lung cancer subreddit, 28 Nov 2015

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.